Narrative review explores the risks of low cholesterol levels in dyslipidemia patients, highlighting cholesterol's dual role in health.
Lowering cholesterol for the health benefit of dyslipidemia is a well-known fact, but emergingevidence highlights risks associated with excessive lowering. The use of lipid-lowering agents toreduce cardiovascular risk is well-established; however, excessive cholesterol reduction has raisedconcerns about the potential health implications of excessively low cholesterol levels. This reviewexplores the "cholesterol paradox," highlighting the dual nature of cholesterol as both a contributor to cardiovascular risk and an essential component for cellular integrity, hormone synthesis, brain function, and vitamin D production. A systematic search of PubMed, Google Scholar, JAMA, andCochrane Library for eligible studies was conducted from 1980 until December 1, 2024. Evidencesuggests that excessively low cholesterol levels may impair cell membrane integrity, neurotransmission, and immune function. This review underscores the need for balanced clinical approach to cholesterol management rather than solely aiming for aggressive reduction, ensuring both cardiovascular protection and broader systemic health.
No takes yet. Share an insight, caveat, or question.
Bashyal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: